Himedi COO on South Korea’s preventive health

From physician-led clinics to consumer brands, U

Wave Life Sciences has moved its next-gen obesit

Human tissue, longitudinal outcomes and multimod

United Therapeutics announced full enrollment of

Haut.

Function launched a secure health data connector

OncoC4 announced that it has dosed the first pati

NeuroQuant PET has received FDA 510(k) clearance

A Danish biotech’s $12 million payment for Alz

GenBio AI’s AIDO Cell links DNA, RNA, protein

Stem cell data showing durable frailty gains ear

New data links Halia’s Alzheimer’s program t

Mesoblast has completed patient treatment in the

Amylyx Pharmaceuticals will announce topline resu

Designerly’s Cooper Adwin explains why the ‘

Insilico Medicine launches a real-world benchmar

New biomarkers promise early disease detection,

The Global Coalition on Aging announced Venus Hea

Insilico launched a Virtual Aging Cell webpage an

Amprion has entered a strategic licensing collabo

Viome announced that it has acquired Circulate He

Novo’s ziltivekimab failure challenges the “

AgelessRx secures $1 million milestone award and

Dallas microbiome company brings physician-devel

Insilico Medicine’s VAC platform makes biologi

Biomodal has launched the duet mosaic family, two

AlzeCure Pharma has received a total upfront paym

Alix Earle has become an investor in Cymbiotika,

BioCardia reported second quarter 2026 financial

AgelessRx has been selected as one of 10 Mileston

AgelessRx has been selected as one of 10 Mileston

NIH-funded GeroSCORE will investigate how sex, m

NIH-funded GeroSCORE will investigate how sex, m

New FDA designation could accelerate development

Silvie Health’s Thomas Schwartz-Dreyfus on why

L’Oréal and NUS Medicine are putting skin, sc

Veradermics reported second-quarter 2026 financia

Lifespan Vision Ventures led Remedium Bio, Inc.

Remedium Bio has completed the initial close of a

Alterity announced that the United States Patent

Kailera Therapeutics reported second quarter 2026

Function announced that it has partnered with NYU

Indian longevity company has moved from lab work

Collaboration aims to strengthen evidence-based

Immorta Bio’s latest blueprint argues longevit

Viome’s acquisition of Circulate Health pairs p

Innovent Biologics and Daiichi Sankyo have entere

Sana Biotechnology reported second quarter 2026 f

Coya Therapeutics provided second quarter 2026 fi